Resmed Inc. buy JPMorgan Chase & Co.
Start price
24.04.25
/
50%
€208.50
Target price
24.04.26
€255.40
Performance (%)
-10.58%
End price
25.04.26
€186.45
Summary
This prediction ended on 25.04.26 with a price of €186.45. The price of Resmed Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.58%. JPMorgan_Chase___Co_ has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 4.038% | 4.038% | -22.138% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $286.00 to $290.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten